Nexalin Technology Inc. (NXL) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nexalin Technology Inc. (NXL:NASDAQ), powered by AI.

Current Price
$0.39
Sector
Healthcare
What is the Nexalin Technology Inc. stock price forecast?

Nexalin Technology Inc. is currently trading at $0.39. View real-time AI analysis on Alpha Lenz.

What is Nexalin Technology Inc. insider trading activity?

View the latest insider trading data for Nexalin Technology Inc. on Alpha Lenz.

What is Nexalin Technology Inc.'s P/E ratio?

View Nexalin Technology Inc.'s valuation metrics on Alpha Lenz.

Nexalin Technology Inc.

NASDAQ · NXL
$0.39-0.01(-2.72%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Nexalin Technology Inc.'s future dividend policy...
Alpha Chat Insight

Nexalin Technology Inc.'s ROE is -221.5%. Explore profitability and growth together.

Ask for details

Company Overview

Nexalin Technology Inc. is a pioneering company in the medical technology sector, specializing in the development of innovative solutions for the treatment of mental health disorders. Its primary focus lies in non-invasive neurostimulation devices designed to help alleviate symptoms of conditions such as anxiety, depression, and insomnia. Utilizing a cutting-edge approach known as transcranial electrical stimulation, Nexalin aims to provide an alternative to pharmaceutical treatments, thereby addressing the growing demand for safer and more effective mental health care options. Nexalin Technology Inc. is significant within the healthcare industry, as it holds the potential to revolutionize the treatment landscape for mental health by offering novel, efficient, and patient-friendly solutions. By aligning with global trends emphasizing mental health awareness and treatment accessibility, the company plays a crucial role in supporting and shaping the future of mental healthcare provision. As the industry evolves, Nexalin continues to explore and expand its technological capabilities, contributing to the overall advancement of medical devices aimed at enhancing mental wellness.

CEOMr. Mark White
SectorHealthcare
IndustryMedical Devices
Employees6

Company Statistics

FY 2025

Profile

N/AMarket Cap
$301.65KRevenue
0.00Shares Out
6Employees

Margins

79.65%Gross
-2816.63%EBITDA
-2781.69%Operating
-2725.42%Pre-Tax
-2725.76%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-38.88%Rev 3Yr
4.43%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-185.64%ROA
-221.50%ROE
-189.45%ROIC

Financial Health

$654.78KCash & Cash Equivalents
$232.55KNet Debt
23.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Nexalin Technology Inc. (ticker: NXL) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 6 employees.

The current price is $0.393 with a P/E ratio of -x and P/B of -x.

ROE is -221.50% and operating margin is -2781.69%. Annual revenue is $301,647.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Nexalin Technology Inc. (NXL) Stock Forecast 2026 $0.39 — Price, Financials & Analyst Targets | Alpha Lenz